RxDoctor Payments Data

Mihir Shah, MD

MOHS-Micrographic Surgery · Westlake, OHNPI 1043605173

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,156, 3.1 times the $371 reported in 2019.

$4,892in general payments, 2019–2025

Across 212 payments — averaging $23.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Incyte Corporation$503
  • Lilly USA, LLC$406
  • Regeneron Healthcare Solutions, Inc.$287
  • UCB, Inc.$243
  • Amgen$230
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$4,892100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,892 in reported general payments places this provider in the 85th percentile of 35 mohs-micrographic surgery providers in Ohio.

See all mohs-micrographic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$899,547
Medicare patients
616
Services billed
2,970

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil11$1,078
Mupirocin140$898
Cephalexin116$301
Doxycycline Hyclate32$259
Minoxidil11$106
ValacyclovirValacyclovir Hcl15$98

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Westlake

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →